Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYXTM/Doxil") versus conventional doxorubicin for first-line treatment of metastatic breast cancer

✍ Scribed by O'Brien, M. E. R.

• Book ID: 111921934
• Publisher: Oxford University Press
• Year: 2004
• Tongue: English
• Weight: 949 KB
• Volume: 15
• Category: Article
• ISSN: 0923-7534
• DOI: 10.1093/annonc/mdh097